Another potential prognostic marker in metabolic syndrome/NASH-associated human liver cancer is arginase 1 (ARG1), whose expression is downregulated in NAFLD/NASH-HCC (Table 1 and Table 2). The gene discussed is ARG1; the disease is metabolic dysfunction-associated steatohepatitis.